Anchor Line Partners and Alloy
complete two leases totaling 67,000 s/f

Bedford, MA  Anchor Line Partners and Alloy, have signed two life sciences leases across its Greater Boston portfolio, totaling 67,000 s/f of biotech manufacturing and office space. 

Lantheus, the leading radiopharmaceutical-focused company, has signed a lease for 41,000 s/f of office space at The Core @ Crosby, located at 34 Crosby Dr. The lease marks a major milestone for the campus, which has completed a comprehensive transformation, including the addition of a new amenity center featuring a café, conference facilities, a fitness center with cold plunge, and an expansive outdoor deck. The nine-building, 592,000 s/f campus is home to some of the area’s preeminent life science and biotechnology companies. With access to I-95 and Rte. 128, a variety of office and lab facilities, and laboratory infrastructure, The Core at Crosby offers an ideal environment for companies to grow and thrive.

The second transaction is a 26,000 s/f lease at The Core @ Waltham. The Core @ Waltham encompasses 360,000 s/f across four buildings and is home to a mature life science hub of some of the most influential companies in the world. The vibrant life sciences ecosystem features contemporary amenities such as a fitness center, collaborative spaces, and outdoor spaces.

“Our ability to attract high-quality tenants like Lantheaus and other biotech companies reflects the resilience of well-located, thoughtfully repositioned assets in a selective market,” said Andrew Maher, co-founder and managing partner of Anchor Line Partners. 

“Through our partnerships with Alloy Properties, we continue to deliver modern, flexible life sciences environments where companies can grow and thrive.”

Anchor Line Partners and Alloy Properties have collaborated on several projects, bringing a combination of deep local knowledge, sector expertise, and vision to acquire and develop innovative campuses in key life sciences clusters across the Greater Boston Area.

Lantheus was advised by Cushman & Wakefield.